Paraovarian/paratubal cysts constitute 5-20% of all adnexal lesions and typically originate from the paramesonephric or Müllerian duct. The primary epithelial tumors arising from paraovarian cysts account for 25% of the cases, but giant cystadenomas of paraovarian origin are extremely uncommon during childhood and adolescence with very few cases reported in the literature. We present the case of a 15-year-old female that presented with a bulky mass in the abdomen and pelvis. An initial clinical and radiological examination indicated an ovarian cyst measuring ∼25x20 cm. However, explorative laparotomy revealed a giant paratubal cyst that was successfully treated with complete excision using fertility-sparing surgery. Histopathological examination was consistent with a serous cystadenoma. The postoperative course was uneventful and the girl was discharged on the seventh postoperative day. At the follow-up of six months, the patient was doing well. Due to their rarity and enormous size, the ...

Serous cystadenoma of ovary with xanthogranulomatous oophoritis: combination of benign ovarian tumour with chronic inflammatory non-neoplastic pseudo-tumour-a rarity

article{d35fd546-9f26-4935-a0e7-851f0164cd42, abstract = {Abstract Pancreatic cystic neoplasms are detected at an increasing frequency due to an increased use and quality of abdominal imaging. There are well known differential diagnostic difficulties concerning these lesions. The aim is to review current literature on the diagnostic options and the following treatment for cystic lesions in the pancreas focusing on serous cystadenomas, primary mucinous neoplasm of the pancreas and mucinous cystadenocarcinomas, as well as intraductal papillary mucinous neoplasms, starting with excluding pseudocysts. A conservative approach is feasible in patients with a clinical presentation suggestive of an asymptomatic serous cystadenoma. Surgical management, as well as follow-up, is discussed for each of the types of neoplastic lesions, including an uncharacterized cyst, based on patient data, symptoms, serum analysis, cyst fluid analysis and morphological features. Aspects for future diagnostics and management ...

TY - JOUR. T1 - Transforming growth factor α levels in pancreatic fluid. AU - Doyle, Courtney J.. AU - Agaram, Narasimhan P.. AU - Yip-Schneider, Michele T.. AU - Schmidt, Christian Max. PY - 2011/3/1. Y1 - 2011/3/1. N2 - OBJECTIVE: To determine if the level of transforming growth factor α (TGF-α) in the pancreatic fluid (PF) can diagnose intraductal papillary mucinous neoplasm (IPMN) versus other cystic lesions of the pancreas in patients. METHODS: Pancreatic fluid was prospectively obtained from patients during routine endoscopy and/or operation at Indiana University Hospital. Pancreatic fluid TGF-α levels were analyzed by enzyme-linked immunosorbent assay. Intraductal papillary mucinous neoplasm tissue was also analyzed by TGF-α immunohistochemistry. RESULTS: Sixty-nine fluid samples from 58 patients with the following pathologically confirmed pancreatic disorders were analyzed: IPMN (26 patients), serous cystadenoma (6), mucinous cystic neoplasm (9), pseudocysts (5), non-IPMN-associated ...

Ann Oncol 2010; 21(1):55-60. 156. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20:1319-1330. 157. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20:1331-1345. 158. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. 234. Scully RE. Gonadoblastoma: a gonadal tumor related to dysgerminoma (seminoma) and capable of sex hormone production. Cancer 1953; 6:455-463. 235. Scully RE. Gonadoblastoma. A review of 74 cases. Cancer 1970; 25:1340-1356. 3d] [28/8/010/18:1:43] [24-36] 2 Preoperative preparation and surgical instrumentation Michael A. Bidus, G. Scott Rose, and John C. Elkas INTRODUCTION The ...

A 74-year-old woman was referred for further evaluation of a large pancreatic cystic lesion. She presented with abdominal discomfort, without weight loss, anorexia or history of pancreatitis or abdominal trauma. Physical examination revealed a large epigastric mass. A contrast-enhanced computed tomography (CT) showed a huge, well-defined, multiloculated cyst of 12cm in greatest dimension arising from the pancreatic body, with multiple wall calcifications, without typical imaging features of a particular pancreatic cystic neoplasm (Fig. 1). Endoscopic ultrasound (EUS) showed a multilocular cyst with a larger cyst (120mm×70mm) and a peripheral microcystic component (Fig. 2). EUS-guided fine-needle aspiration of 7mL of serous cystic fluid was performed from the largest cyst under prophylactic IV antibiotics. The sample had no malignant or mucus-producing cells and CEA (,2.5ng/mL) and amylase (41U/L) were within the reference values, making a serous cystadenoma the most likely diagnosis. Due to ...

In this case we report a 23 -year-old primigravida with 30 weeks presenting with torsion of the ovarian cyst. She presented to the antenatal clinic with acute pain abdomen. She was diagnosed to have torsion of ovarian cyst during pregnancy and a cystecomy was carried out. Her histopathology report showed a benign serous cystadenoma. Her pregnancy was followed up. She delivered a healthy female baby at term. Although the safety of antepartum surgical intervention has been accepted, abdominal surgery nevertheless carries some risks to a pregnant woman and unborn fetus, and so the choice of management necessitates a weighing of risks based on characterization of the adnexal mass and gestational age.

Top 10 cancers for 1552950_at (Homo sapiens, Affymetrix Probeset): spinal cord, ependymoma, NOS, spinal cord, connective and soft tissue, fibrous histiocytoma tumor cells, malignant, bone / articular cartilage, ependymoma, NOS, brain, ependymoma, NOS, ovary, serous cystadenoma, borderline malignancy, skin, malignant melanoma, NOS, metastatic, cerebrum, ependymoma, NOS, acute myeloid leukemia (FAB M4Eo), malignant melanoma of skin

Looking for online definition of appendicitis in the medical dictionary? appendicitis explanation free. what is appendicitis? meaning of appendicitis medical term.. Find information on liver disease in dogs and conditions of the pancreas at peteducation.com. articles about dog liver problems and the pancreas written by our. Home chapter home jobs conferences fellowships books. advertisement. pancreas. tumors. serous cystadenoma. reviewer: deepali jain, m.d. (see reviewers page). ...

Giant abdominal cyst can lead to various non-specific symptoms such as abdominal bloating, nausea/vomiting, constipation due to its mass effect. In rarer circumstances, it can lead to bowel obstruction, hydronephrosis and even abdominal compartment syndrome. Hereby, we present a case of giant abdominal cyst in a young woman where its origin was a diagnostic dilemma despite exhausting all imaging techniques. A laparotomy was performed and the giant cyst was found to be originating from the left ovary. The final histopathology confirmed it as an ovarian benign serous cystadenoma. The patient made a fully recovery without any complications. ...

1. Altgassen C., Hertel H., Brandstädt A., Köhler C., Dürst M., Schneider A. & Study Group A.G.O.: Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol: 26 2943-51, 2008 2. Baessler K., ONeill S.M., Maher C.F. & Battistutta D.: An interviewer-administered validated female pelvic floor questionnaire for community-based research. Menopause: 15 973-7, 2008 3. Bischoff A., Marnitz S., Köhler C., Kurzeja R., Morawietz L., Schneider A. & Budach V.: Complete remission after neoadjuvant chemoradiation in a stage IV vulvar cancer patient. Strahlenther Onkol: 184 421-5, 2008 4. Ebert A.D., Rosenow G., David M., Mechsner S., Magalov I.S. & Papadopoulos T.: Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer. Gynecol Obstet Inves: 66 209-213, 2008 5. ...

Background: Ovarian cancer is the most deadly malignancy of the female reproductive tract. Ovarian epithelial tumours are considered to be endocrine related, but the factors that govern their genesis and progression remain unclear. Radical surgery and recent advances in chemotherapy have only moderately improved survival rates. Biological and endocrine approaches may help to satisfy the pressing need for alternative therapies.. Aims: The aims of the studies included in this thesis were to isolate and culture ovarian tumour cells with a high epithelial cell fraction (ECF) and to evaluate the fluorometric microculture cytotoxity assay (FMCA) as a tool in the development of alternative therapies. We also aimed to measure the effects of bispecific antibodies (BsAbs) directed against three ovarian tumour markers, separately and in combination, and to study the effects of sex steroids on tumour cell survival, on autonomous steroid secretion and on the expression of estrogen (ER) and progesterone ...

This review focuses on recent advances in the area of low-grade ovarian serous neoplasia with emphasis on key diagnostic criteria, differential diagnosis, and disease classification based on current understanding of low-grade serous carcinogenesis. Despite considerable controversy surrounding serous tumors of low malignant potential (S-LMP) or borderline tumors, there have been great strides in our understanding of the serous group of borderline and malignant pelvic epithelial neoplasms in the past decade. Most S-LMP have a favorable prognosis, but recurrences and progression to carcinoma occur, sometimes following a protracted clinical course. Pathologic risk factors vary, but the extraovarian implant status is the most important predictor for progressive disease. Progression of S-LMP usually takes the form of low-grade serous carcinoma, although transformation to high-grade carcinoma is occasionally seen. A pelvic S-LMP - low-grade serous carcinoma pathway has been proposed based on global gene

Dr. Natalie Banet moderates the discussion of studies pertinent to the practice of Gynecological Pathology, led by pathology trainees. Articles to be covered: Zarei S, et al. Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma. Am J Surg Pathol. 2020;44(3):316-328. Seidman JD, et al. Intratumoral Heterogeneity Accounts for Apparent Progression of Noninvasive Serous Tumors to Invasive Low-grade Serous Carcinoma: A Study of 30 Low-grade Serous Tumors of the Ovary…. ...

Serous cystadenomas are a type of cystic neoplasm of the pancreas. These lesions are more frequent in those greater than age 70 and are more common in women. They are commonly quite large at the time of diagnosis measuring on average 5-8cm. Even though they are large they almost never cause jaundice and uncommonly will block the pancreatic duct. Thus, they are usually asymptomatic and are most usually found on diagnostic imaging performed for other reasons.. ...

Gandhi NS and Hecht E. Adding Value to Clinical Care: Structured Reporting of Pancreatic Pathology, Workshop Session Presentation, Society of Abdominal Radiology Annual Meeting, ...

Yeast, Stem Cells, Cobalt, Asparagine, Glutamine, Patients, Neoplasms, Pancreas, Biomarkers, Cyst, Mutations, Tumor, and Mutation

We encountered two cases of endometrioid carcinoma of uterus with extensive surface epithelial changes (SECs) mimicking serous borderline tumor (SBT) of the ovary. The first case was a well-differentiated endometrioid carcinoma arising in a background of complex atypical hyperplasia. The second case was moderately-differentiated endometrioid carcinoma with squamous and mucinous differentiation. The SECs comprised of thin microapapillae without hierarchal branching, lined by cuboidal cells with eosinophilic cytoplasm and mild to moderate nuclear atypia. These areas were reminiscent of SBTs of ovary, micropapillary type. This report expands the existing spectrum of SECs. Serous borderline tumor of ovary like surface epithelial changes could be misleading if present in an endometrial biopsy or curettings. Therefore, knowledge of this morphologic variation is important.

TY - JOUR. T1 - Low-grade serous carcinoma (mullerian/ovarian type) of the paratestis presenting as diffuse metastatic disease of unknown origin. T2 - Case report of an uncommon tumor with an unusual presentation. AU - Filatenkov, Alexander. AU - Strickland, Amanda. AU - Karpowicz, Matthew. AU - Francis, Franto. N1 - Publisher Copyright: © 2017 The Authors Copyright: Copyright 2017 Elsevier B.V., All rights reserved.. PY - 2018/3. Y1 - 2018/3. N2 - Low-grade (papillary) serous carcinoma of ovarian type is rare in males and histologically identical to low-grade serous carcinomas in female patients. We present a case of paratesticular low-grade serous carcinoma in a 42 year old male, with the highly unusual initial presentation as diffuse metastatic disease in the abdomen. Imaging revealed a cystic lesion of the right testis/hemiscrotum. Biopsy of the abdominal metastasis and subsequent right orchiectomy specimen showed invasive papillary serous carcinoma, low grade, with prominent psammomatous ...

TY - JOUR. T1 - Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum. AU - Hinson, Stacy A.. AU - Silva, Elvio G.. AU - Pinto, K.. PY - 2013/6/1. Y1 - 2013/6/1. N2 - Ovarian serous cystadenofibromas are benign neoplasms that sometimes have focal areas of borderline serous tumor and rarely have been associated with epithelial proliferations in the peritoneum, resembling implants. We are reporting 2 cases of ovarian serous cystadenofibromas with serous peritoneal lesions of higher grade than the ovarian tumor: 1 case had a serous carcinoma and another 1 a serous borderline tumor.. AB - Ovarian serous cystadenofibromas are benign neoplasms that sometimes have focal areas of borderline serous tumor and rarely have been associated with epithelial proliferations in the peritoneum, resembling implants. We are reporting 2 cases of ovarian serous cystadenofibromas with serous peritoneal lesions of higher grade than the ovarian tumor: 1 case had a serous ...

Case report: A 50 year old woman presented with lower abdominal pain and fullness. On radiological examination, a left ovarian, predominantly cystic mass about 10cm in diameter was found along with an uterine nodule, 1.5cm in diameter, presumed to be a leiomyoma. The ovarian cyst on histology was diagnosed as ESS arising in a serous cystadenoma. The uterine nodule was diagnosed as ESN since there was no myometrial or vascular invasion ...

Mucinous cystadenomas are rare benign epithelial ovarian tumors which are commonly found in middle aged women and are bilateral in 10 percent cases. These tumors are known to grow to massive sizes with historical recordings of removal of a 137.4 kg tumor by Ohanlan in 1994.[2] Our patient had a 21x19.5x13 cm mass that weighed 3.650 kg and could luckily be removed intact despite her history of 3 caesarean sections in the past. Traditionally the epithelial lining of mucinous cystadenomas can be one of 3 types - endocervical, intestinal or the mullerian type. Our patient had a mucinous borderline tumor of the intestinal type with only atypia. The patient fell into FIGO stage 1a for borderline ovarian tumors.[4] The 5 year survival in such patients is usually more than 99%.[5] The cytoplasm of epithelia of low malignant potential mucinous tumours is more basophilic than the epithelium of mucinous cystadenoma. They also show occasional evidence of inflammatory infilitrates. In general in borderline ...

TY - JOUR. T1 - Cystadenomas of the pancreas. T2 - Is enucleation an adequate operation?. AU - Talamini, Mark Adams. AU - Moesinger, Robert. AU - Yeo, Charles J.. AU - Poulose, Benjamin. AU - Hruban, Ralph H.. AU - Cameron, John L.. AU - Pitt, Henry A.. PY - 1998/6/1. Y1 - 1998/6/1. N2 - Objective: The objective was to determine whether surgical enucleation of mucinous cystadenoma of the pancreas is a safe and adequate operation. Summary Background Data: Mucinous cystadenomas of the pancreas are premalignant cystic lesions. Resection is the preferred treatment but often requires a pancreatoduodenectomy or a distal pancreatectomy with or without a splenectomy. Although these procedures can now be performed with a low mortality rate, substantial morbidity still occurs, especially in patients who have an otherwise normal pancreas. Methods: Between January 1990 and June 1997, 36 mucinous cystadenomas of the pancreas were resected at The Johns Hopkins Hospital. Most of these patients underwent ...

A 53-yr-old woman with a history of hepatic cystadenoma 25 yr before presented with a simple hepatic cyst, which evolved over 9 yr into a complex cystadenoma with septations and internal bleeding. She was treated with a left hepatectomy. Review of the literature shows that hepatic cystadenomas, although rare, frequently can recur years later and have potential for malignant transformation. Histologic similarities of one variant with ovarian stroma raises interesting possibilities regarding the origin of these lesions. The best treatment results are obtained with radical excision ...

Context: Ovarian tumours represent about 30% of all cancers of the female genital system. They manifest in a wide spectrum of clinical, morphological and histological features. Aim: To study the frequency of incidence of different histopathological types of ovarian tumours in our institute. Materials and Methods: This retrospective study included 257 cases of histopathologically proven ovarian tumours, reported in the Department of Pathology of a rural tertiary care referral hospital, over a 12 year period (January 2000 to December 2011). These were classifi ed according to the WHO classifi cation of ovarian tumours (2003). Clinical presentation of the patients was analysed from archived case records. Results: Of the 257 tumours studied, 162 (63.04%) were benign, 15 (5.84%) were borderline and 80 (31.12%) were malignant. Surface epithelial tumours were the most common (68.48%) followed by germ cell tumours (15.95%). Mucinous cystadenomas (32.69%) were the most common benign tumours, while serous ...

Epigenetic aberrations have been shown to be intimately associated with ovarian tumorigenesis (10, 11). A number of genes including the classic tumor suppressor, BRCA1, p16, MLH1, RASSF1A, ANGPTL2, ARH1, LOT1, ICAM1, HSulf-1, PALB2, and TUBB3 have been shown to be hypermethylated and downregulated in ovarian cancer (11). In the present study, we showed that downregulation of FILIP1L (previously termed DOC1) is associated with DNA methylation in ovarian cancer. We have shown that both the mRNA and protein expression of FILIP1L are downregulated in ovarian cancer cells. FILIP1L expression is significantly lower in invasive serous carcinoma than in noninvasive serous borderline tumors. FILIP1L expression is inversely correlated with the invasive potential of ovarian cell lines as well as clinical ovarian specimens. The CpG island in the FILIP1L promoter is heavily methylated in ovarian cancer cells and almost completely nonmethylated in normal HOSE cells. The DNA methylation status of the FILIP1L ...

Tumor-infiltrating neutrophil (TIN) has been reported to be an independent predictor in multiple tumors, but its role in the development of adenocarcinoma of the esophagogastric junction (AEG)...

NAD(P)H:quinone oxidoreductase (NQO1) is a flavoprotein that catalyzes two-electron reduction and detoxification of quinones and its derivatives. NQO1 catalyzes reactions that have a protective effect against redox cycling, oxidative stress and neoplasia. High expression of NQO1 is associated with many solid tumors including those affecting the colon, breast and pancreas; however, its role in the progression of ovarian carcinoma is largely undefined. This study aimed to investigate the clinicopathological significance of high NQO1 expression in serous ovarian carcinoma. NQO1 protein expression was assessed using immunohistochemical (IHC) staining in 160 patients with serous ovarian carcinoma, 62 patients with ovarian borderline tumors and 53 patients with benign ovarian tumors. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect NQO1 mRNA expression levels. The correlation between high NQO1 expression and clinicopathological features of ovarian carcinoma was evaluated by

Dishevelled family proteins (DVL1, DVL2 and DVL3) are cytoplasmic mediators involved in canonical and non-canonical Wnt signaling that are important for embryonic development. Since Wnt signaling promotes cell proliferation and invasion, its increased activation is associated with cancer development as well. To get deeper insight into the behavior of Dishevelled proteins in cancer, we studied their expression in serous ovarian carcinomas [both low- (LGSC) and high-grade (HGSC)], and HGSC cell lines OVCAR5, OVCAR8 and OVSAHO. DVL protein expression in serous ovarian carcinomas tissues was analyzed using immunohistochemistry while DVL protein and mRNA expressions in HGSC cell lines were analyzed using western blot and quantitative real-time PCR. DVL1 protein expression was significantly higher in LGSC compared with normal ovarian tissue, while DVL3 was overexpressed in both LGSC and HGSC. DVL2 and DVL3 protein expression was higher in HGSC cell lines when compared with normal control cell line ...

GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2020 Jan 11;:109539 Authors: El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, Abd-Allah AR, Sood AK, Lopez-Berestein G Abstract High-grade serous ovarian carcinoma (HGSOC) is the mos...

TY - JOUR. T1 - The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia Prepared by. AU - ASGE Standards of Practice Committee. AU - Eloubeidi, Mohamad A.. AU - Decker, G. Anton. AU - Chandrasekhara, Vinay. AU - Chathadi, Krishnavel V.. AU - Early, Dayna S.. AU - Evans, John A.. AU - Fanelli, Robert D.. AU - Fisher, Deborah A.. AU - Foley, Kimberly. AU - Hwang, Joo Ha. AU - Jue, Terry L.. AU - Lightdale, Jenifer R.. AU - Pasha, Shabana F.. AU - Saltzman, John R.. AU - Sharaf, Ravi. AU - Shergill, Amandeep K.. AU - Cash, Brooks D.. AU - DeWitt, John M.. PY - 2016/1/1. Y1 - 2016/1/1. N2 - This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this document that updates a previously issued consensus statement and a technology status evaluation report on this topic.1 In preparing this guideline, a search ...

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.

Surgical resection of borderline epithelial ovarian tumors (costs for program #130589) ✔ University Hospital Giessen UKGM ✔ Department of Gynecology and Obstetrics ✔ BookingHealth.com

美国,旧金山,洛杉矶,纽约,生活,华人,中文,百科知识,移民,租房,买房,保险,汽车,招聘,求职,求助,租车,保姆,月嫂,家政,用工

Home / Research / Super-heavy pyrite (δ 34Spyr , δ 34SCAS) in the terminal Proterozoic Nama Group, Southern Namibia: A consequence of low seawater sulfate at the dawn of animal life ...

See also ; ovarian tumors Appearance : ovarian epithelial tumors ovarian serous tumors benign ovarian serous tumors proliferating (...)

https://doi.org/10.18632/oncotarget.21175 Véronique DHondt, Magalie Lacroix-Triki, Marta Jarlier, Florence Boissiere-Michot, Carole Puech, Peter Coopman, Dionyssios Katsaros, Gilles Freiss

To determine the prognosis and prognostic factors in a large series of mucinous borderline tumors of the ovary (MBOT).A retrospective review of patients with ...

A psammoma body is a round collection of calcium, seen microscopically. The term is derived from the Greek word ψάμμος (psámmos), meaning sand. Psammoma bodies are associated with the papillary (nipple-like) histomorphology and are thought to arise from (1) the infarction and calcification of papillae tips and (2) calcification of intralymphatic tumor thrombi. Psammoma bodies are commonly seen in certain tumors such as: Papillary thyroid carcinoma Papillary renal cell carcinoma Micropapillary subtype of lung adenocarcinoma Ovarian papillary serous cystadenoma and cystadenocarcinoma Endometrial adenocarcinomas (Papillary serous carcinoma ~3%-4%) Meningiomas, in the central nervous system Peritoneal and Pleural Mesothelioma Somatostatinoma (pancreas) Prolactinoma of the pituitary ... Psammoma bodies may be seen in: Endosalpingiosis Psammomatous melanotic schwannoma Melanocytic nevus Psammoma bodies usually have a laminar appearance, are circular, acellular and basophilic. Johannessen JV, ...

Histologically, cystoadenomas are characterised by the presence of cysts lined with mucinous cuboidal or columnar epithelium.6 An ovarian-type stroma is seen in 85% of cases and exclusively in females.4 A marsupial pseudocapsule separates the cystadenoma from the biliary epithelium.4 Elevated levels of CA 19-9 and/or CEA have been reported within the cysts themselves.1 2 4 11 12. Although the biliary cystadenoma is a benign entity, malignant transformation can occur, leading to cystadenocarcinoma.4 Sarcomatous transformation has also been described in one case.6 It has been suggested that cystadenocarcinomas arising from biliary cystadenomas with ovarian-type stroma have a relatively indolent course, whereas cystadenomas without ovarian-type stroma have a poorer prognosis.4. Most commonly, on radiologic imaging, these neoplasms appear as multi-loculated, multi-septated intrabiliary neoplasms. They are usually large at the time of presentation, with a mean tumour size of 15 centimetres.4 On CT, ...

Symptoms. Mucinous Cystadenocarcinomas are more common in the body and tail of the pancreas. They can be more prominent then 10 centimeters. Guess with this kind of pancreatic cancer for the most part better. Pancreatoblastomas are uncommon (0.5 percent) exocrine tumors commonly found in children under 10 years of age, however it can happen all through lifetime. Pancreatoblastomas are recognized all the more regularly in guys and Asians. They show up as a group of cells among ordinary cells. Survival is superior to with adenocarcinoma.. Serous Cystadenomas are ordinarily kindhearted tumors. They have a wipe like improvement and can be cumbersome. They are loaded with watery fluid, while mucinous cystadenomas are loaded with a thicker sticky liquid. Serous cystadenomas comprise of single or different growths averaging 5-8 cm and upwards to 25 cm in breadth. Papillary Tumors are uncommon with an inclination for young ladies principally between 19 - 50 years of age. It is a huge round very much ...

Biliary cystadenomas are benign but potentially malignant cystic neoplasms, which classically contain mesenchymal stroma similar to ovarian tissue. We report a case of an extra-hepatic biliary cystadenoma with mesenchymal stroma along with a discussi

The TP53 gene mutation frequency in ovarian serous carcinomas has been reported to range between 50% and 80%. A research team working at the The Sidney Kimmel Comprehensive Cancer Center of The Johns Hopkins Medical Institutions (Johns Hopkins) made several important findings regarding TP53 gene mutations with respect to high grade ovarian serous carcinoma, as reported in the International Journal of Gynecological Cancer. Ovarian serous carcinoma is the most common tumor subtype within the epithelial ovarian cancer histological classification.. According to the Johns Hopkins research team, a stringent analysis of the TP53 gene using purified epithelial tumor samples has not been performed to accurately assess the TP53 gene mutation frequency and its correlation to tumor histologic grade. The research team assessed the TP53 gene mutational profile in a relatively large series of high-grade (53 primary tumors and 18 recurrent tumors) and 13 low-grade ovarian serous tumors. All samples were ...

The TP53 mutation frequency in ovarian serous carcinomas has been reported to range between 50% and 80%, but a stringent analysis of TP53 using purified epithelial samples has not yet been performed to accurately assess the mutation frequency and to correlate it with the histologic grade. The purpose of this study was to assess the TP53 mutational profile in a relatively large series of high-grade (53 primary and 18 recurrent) and 13 low-grade ovarian serous tumors using DNA isolated from affinity-purified tumor cells and to correlate it with in vitro drug resistance. All samples were affinity purified, and the tumor DNA was analyzed for TP53 mutations in exons 4-9. In vitro drug resistance assays to carboplatin, cisplatin, paclitaxel, and taxotere were performed on the same tumor samples and correlated with the TP53 mutation status. TP53 mutations were detected in 57 (80.3%) of 71 high-grade carcinomas and in one (7.8%) of 13 low-grade serous tumors (an invasive low-grade serous carcinoma). The ...

Robot-Assisted Laparoscopic Vesiculectomy for Large Seminal Vesicle Cystadenoma: A Case Report and Review of the Literature. ( 25862321 ) ...

1. Cadron, I., Leunen, K., Van Gorp, T., et al. Management of borderline ovarian neoplasms. J Clin Oncol, 2007, 25, p. 2928-2937. 2. Chambers, JT., Merino, MJ., Kohorn, EI., Schwartz, PE. Borderline ovarian tumors. Am J Obstet Gynecol, 1988, 159, p. 1088-1094. 3. Darai, E., Fauvet, R., Uzan, C., et al. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update, 2013, 19, p. 151-166. 4. Fauvet, R., Boccara, J., Dufourmet, C., et al. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol, 2005, 16, p. 403-410. 5. Hoskins, PJ. Ovarian tumors of low malignant potential: borderline epithelial ovarian carcinoma. In Lawton, FG., Neijt, JP., Swenerton, KD. (eds) Epithelial cancer of the ovary. London: BMJ Publishing Group. 1995, p. 112-136. 6. Kaern, JT., Trope, CG., Abeler, VM. A retrospective study of 370 borderline tumours of the ovary treated at the Norwegian ...

Borderline epithelial ovarian tumors Diagnosis (costs for program #248705) ✔ University Hospital Halle (Saale) ✔ Department of Gynecology and Mammology ✔ BookingHealth.com

Low grade serous ovarian cancer affects approximately 1 in 1000 women, many will be diagnosed in their 20s and 30s. With current medical treatments ...

Risk of Malignancy in Unilocular Ovarian Cystic Tumors Less Than 10 Centimeters in Diameter Susan C. Modesitt, MD, Edward J. Pavlik, PhD, Frederick R. Ueland, MD, Paul D. DePriest, MD, R. J. Kryscio, PhD,

Hi all, I am cross posting this since I think I initially posted to the wrong forum. I had what my dr. though were 2 dermoid cysts (one one each ovary). I had a laproscopic procedure to remove bo...